Company / Capital Expenditures
Cocrystal Pharma, Inc. Capital Expenditures History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$52.0K
FY2021
5-year range
$28.0K / $152.1K
FY2017-FY2021
Trend
-64.1%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $28,000 to $52,000 over the past 2 years.
Based on SEC 10-K filings.
$52,000 in FY2021.
Improved from $28,000 to $52,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, capital expenditures decreased 64.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $52.0K | -64.1% |
| FY2020 | $145.0K | +417.9% |
| FY2019 | $28.0K | -81.6% |
| FY2012 | $152.1K | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026